• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

厄洛替尼介导的 EGFR 信号抑制通过 NOX4 诱导代谢氧化应激。

Erlotinib-mediated inhibition of EGFR signaling induces metabolic oxidative stress through NOX4.

机构信息

Free Radical and Radiation Biology Program, Department of Radiation Oncology, Holden Comprehensive Cancer Center, The University of Iowa, Iowa City, Iowa 52242, USA.

出版信息

Cancer Res. 2011 Jun 1;71(11):3932-40. doi: 10.1158/0008-5472.CAN-10-3425. Epub 2011 Apr 11.

DOI:10.1158/0008-5472.CAN-10-3425
PMID:21482679
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3217301/
Abstract

Redox regulation of epidermal growth factor receptor (EGFR) signaling helps protect cells against oxidative stress. In this study, we investigated whether the cytotoxicity of an EGFR tyrosine kinase inhibitor, erlotinib (ERL), was mediated by induction of oxidative stress in human head and neck cancer (HNSCC) cells. ERL elicited cytotoxicity in vitro and in vivo while increasing a panel of oxidative stress parameters which were all reversible by the antioxidant N-acetyl cysteine. Knockdown of EGFR by using siRNA similarly increased these oxidative stress parameters. Overexpression of mitochondrial targeted catalase but not superoxide dismutase reversed ERL-induced cytotoxicity. Consistent with a general role for NADPH oxidase (NOX) enzymes in ERL-induced oxidative stress, ERL-induced cytotoxicity was reversed by diphenylene iodonium, a NOX complex inhibitor. ERL reduced the expression of NOX1, NOX2, and NOX5 but induced the expression of NOX4. Knockdown of NOX4 by using siRNA protected HNSCC cells from ERL-induced cytotoxicity and oxidative stress. Our findings support the concept that ERL-induced cytotoxicity is based on a specific mechanism of oxidative stress mediated by hydrogen peroxide production through NOX4 signaling.

摘要

氧化还原调节表皮生长因子受体(EGFR)信号有助于保护细胞免受氧化应激。在这项研究中,我们研究了 EGFR 酪氨酸激酶抑制剂厄洛替尼(ERL)的细胞毒性是否通过诱导人头颈癌(HNSCC)细胞中的氧化应激来介导。ERL 在体外和体内均表现出细胞毒性,同时增加了一系列氧化应激参数,这些参数均可通过抗氧化剂 N-乙酰半胱氨酸逆转。使用 siRNA 敲低 EGFR 同样增加了这些氧化应激参数。过表达靶向线粒体的过氧化氢酶而不是超氧化物歧化酶可逆转 ERL 诱导的细胞毒性。与 NADPH 氧化酶(NOX)酶在 ERL 诱导的氧化应激中的一般作用一致,NOX 复合物抑制剂二苯碘鎓可逆转 ERL 诱导的细胞毒性。ERL 降低了 NOX1、NOX2 和 NOX5 的表达,但诱导了 NOX4 的表达。使用 siRNA 敲低 NOX4 可保护 HNSCC 细胞免受 ERL 诱导的细胞毒性和氧化应激。我们的发现支持这样一种观点,即 ERL 诱导的细胞毒性是基于通过 NOX4 信号产生过氧化氢介导的特定氧化应激机制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3ec/3217301/8010eff08c0a/nihms288205f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3ec/3217301/c55787b52d4d/nihms288205f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3ec/3217301/118c19b34cf1/nihms288205f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3ec/3217301/a5ca261dd5ed/nihms288205f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3ec/3217301/b54dd3186083/nihms288205f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3ec/3217301/8010eff08c0a/nihms288205f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3ec/3217301/c55787b52d4d/nihms288205f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3ec/3217301/118c19b34cf1/nihms288205f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3ec/3217301/a5ca261dd5ed/nihms288205f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3ec/3217301/b54dd3186083/nihms288205f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3ec/3217301/8010eff08c0a/nihms288205f5.jpg

相似文献

1
Erlotinib-mediated inhibition of EGFR signaling induces metabolic oxidative stress through NOX4.厄洛替尼介导的 EGFR 信号抑制通过 NOX4 诱导代谢氧化应激。
Cancer Res. 2011 Jun 1;71(11):3932-40. doi: 10.1158/0008-5472.CAN-10-3425. Epub 2011 Apr 11.
2
NOX4 mediates cytoprotective autophagy induced by the EGFR inhibitor erlotinib in head and neck cancer cells.NOX4 介导表皮生长因子受体抑制剂厄洛替尼诱导的头颈部癌细胞保护性自噬。
Toxicol Appl Pharmacol. 2013 Nov 1;272(3):736-45. doi: 10.1016/j.taap.2013.07.013. Epub 2013 Jul 31.
3
EGFR inhibition induces proinflammatory cytokines via NOX4 in HNSCC.EGFR 抑制通过 NOX4 在头颈部鳞状细胞癌中诱导促炎细胞因子。
Mol Cancer Res. 2013 Dec;11(12):1574-84. doi: 10.1158/1541-7786.MCR-13-0187. Epub 2013 Sep 18.
4
Elevated RET expression enhances EGFR activation and mediates EGFR inhibitor resistance in head and neck squamous cell carcinoma.RET表达升高增强了头颈部鳞状细胞癌中的表皮生长因子受体(EGFR)激活并介导EGFR抑制剂耐药。
Cancer Lett. 2016 Jul 10;377(1):1-10. doi: 10.1016/j.canlet.2016.04.023. Epub 2016 Apr 18.
5
ASCT2 (SLC1A5) is an EGFR-associated protein that can be co-targeted by cetuximab to sensitize cancer cells to ROS-induced apoptosis.ASCT2(溶质载体家族1成员5)是一种与表皮生长因子受体(EGFR)相关的蛋白质,可被西妥昔单抗共同靶向,使癌细胞对活性氧诱导的凋亡敏感。
Cancer Lett. 2016 Oct 10;381(1):23-30. doi: 10.1016/j.canlet.2016.07.020. Epub 2016 Jul 19.
6
2-Deoxy-d-glucose Suppresses the In Vivo Antitumor Efficacy of Erlotinib in Head and Neck Squamous Cell Carcinoma Cells.2-脱氧-D-葡萄糖抑制厄洛替尼在头颈部鳞状细胞癌细胞中的体内抗肿瘤疗效。
Oncol Res. 2016;24(1):55-64. doi: 10.3727/096504016X14586627440192.
7
Preclinical modeling of EGFR inhibitor resistance in head and neck cancer.头颈部癌中表皮生长因子受体抑制剂耐药的临床前模型。
Cancer Biol Ther. 2012 Aug;13(10):935-45. doi: 10.4161/cbt.20846. Epub 2012 Aug 1.
8
Honokiol inhibits epidermal growth factor receptor signaling and enhances the antitumor effects of epidermal growth factor receptor inhibitors.和厚朴酚抑制表皮生长因子受体信号通路并增强表皮生长因子受体抑制剂的抗肿瘤作用。
Clin Cancer Res. 2010 May 1;16(9):2571-9. doi: 10.1158/1078-0432.CCR-10-0333. Epub 2010 Apr 13.
9
Dacomitinib, an irreversible Pan-ErbB inhibitor significantly abrogates growth in head and neck cancer models that exhibit low response to cetuximab.达可替尼,一种不可逆的泛 ErbB 抑制剂,可显著抑制对西妥昔单抗反应较低的头颈部癌症模型的生长。
PLoS One. 2013;8(2):e56112. doi: 10.1371/journal.pone.0056112. Epub 2013 Feb 6.
10
Monensin inhibits epidermal growth factor receptor trafficking and activation: synergistic cytotoxicity in combination with EGFR inhibitors.莫能菌素抑制表皮生长因子受体的运输和激活:与 EGFR 抑制剂联合具有协同细胞毒性。
Mol Cancer Ther. 2014 Nov;13(11):2559-71. doi: 10.1158/1535-7163.MCT-13-1086. Epub 2014 Sep 4.

引用本文的文献

1
Prognostic Impact of Reactive Oxygen Species Modulator 1 in Surgically Resected Epidermal Growth Factor Receptor-Mutant Lung Adenocarcinomas.活性氧调节剂 1 在手术切除的表皮生长因子受体突变型肺腺癌中的预后影响。
Oncology. 2024;102(11):969-978. doi: 10.1159/000540521. Epub 2024 Jul 25.
2
Promoting reactive oxygen species accumulation to overcome tyrosine kinase inhibitor resistance in cancer.促进活性氧积累以克服癌症中的酪氨酸激酶抑制剂耐药性。
Cancer Cell Int. 2024 Jul 9;24(1):239. doi: 10.1186/s12935-024-03418-x.
3
Iron, Ferroptosis, and Head and Neck Cancer.

本文引用的文献

1
EGFR tyrosine kinase inhibitors and multidrug resistance: perspectives.表皮生长因子受体酪氨酸激酶抑制剂与多药耐药:展望。
Front Biosci (Landmark Ed). 2011 Jan 1;16(5):1811-23. doi: 10.2741/3823.
2
Metastasis: cancer cell's escape from oxidative stress.转移:癌细胞逃避氧化应激。
Cancer Metastasis Rev. 2010 Jun;29(2):351-78. doi: 10.1007/s10555-010-9225-4.
3
Inhibition of glutathione and thioredoxin metabolism enhances sensitivity to perifosine in head and neck cancer cells.抑制谷胱甘肽和硫氧还蛋白代谢可增强头颈癌细胞对帕比司他的敏感性。
铁、铁死亡与头颈部肿瘤。
Int J Mol Sci. 2023 Oct 12;24(20):15127. doi: 10.3390/ijms242015127.
4
β-AR inhibition enhances EGFR antibody efficacy hampering the oxidative stress response machinery.β-AR 抑制增强了 EGFR 抗体的疗效,从而抑制了氧化应激反应机制。
Cell Death Dis. 2023 Sep 19;14(9):613. doi: 10.1038/s41419-023-06129-9.
5
Cardiovascular toxicity of tyrosine kinase inhibitors during cancer treatment: Potential involvement of TRPM7.癌症治疗期间酪氨酸激酶抑制剂的心血管毒性:TRPM7的潜在作用。
Front Cardiovasc Med. 2023 Feb 3;10:1002438. doi: 10.3389/fcvm.2023.1002438. eCollection 2023.
6
Potential ferroptosis-related diagnostic and prognostic biomarkers in laryngeal cancer.喉癌中潜在的铁死亡相关诊断和预后生物标志物
Eur Arch Otorhinolaryngol. 2022 Nov;279(11):5277-5288. doi: 10.1007/s00405-022-07433-4. Epub 2022 Jul 12.
7
The Role of ROS as a Double-Edged Sword in (In)Fertility: The Impact of Cancer Treatment.活性氧作为双刃剑在(不)孕中的作用:癌症治疗的影响
Cancers (Basel). 2022 Mar 21;14(6):1585. doi: 10.3390/cancers14061585.
8
Electron transfer-triggered imaging of EGFR signaling activity.电子转移触发的 EGFR 信号转导活性成像。
Nat Commun. 2022 Feb 1;13(1):594. doi: 10.1038/s41467-022-28213-y.
9
Overexpression of Reactive Oxygen Species Modulator 1 Predicts Unfavorable Clinical Outcome in EGFR-Mutant Lung Adenocarcinomas Treated With Targeted Therapy.活性氧调节剂1的过表达预示着接受靶向治疗的EGFR突变型肺腺癌患者临床预后不良。
Front Oncol. 2021 Dec 9;11:770230. doi: 10.3389/fonc.2021.770230. eCollection 2021.
10
Autophagy awakens-the myriad roles of autophagy in head and neck cancer development and therapeutic response.自噬觉醒——自噬在头颈部癌症发生和治疗反应中的多种作用。
Mol Carcinog. 2022 Feb;61(2):243-253. doi: 10.1002/mc.23372. Epub 2021 Nov 15.
J Oncol. 2009;2009:519563. doi: 10.1155/2009/519563. Epub 2009 Sep 2.
4
Subcellular localization of Nox4 and regulation in diabetes.Nox4的亚细胞定位及在糖尿病中的调控
Proc Natl Acad Sci U S A. 2009 Aug 25;106(34):14385-90. doi: 10.1073/pnas.0906805106. Epub 2009 Aug 17.
5
Reactive oxygen species-dependent signaling regulates cancer.活性氧物种依赖性信号传导调控癌症。
Cell Mol Life Sci. 2009 Dec;66(23):3663-73. doi: 10.1007/s00018-009-0099-y. Epub 2009 Jul 24.
6
Roles of Nox1 and other Nox isoforms in cancer development.Nox1及其他Nox亚型在癌症发展中的作用。
Cancer Sci. 2009 Aug;100(8):1382-8. doi: 10.1111/j.1349-7006.2009.01207.x. Epub 2009 May 4.
7
Nox4 NADPH oxidase mediates oxidative stress and apoptosis caused by TNF-alpha in cerebral vascular endothelial cells.Nox4烟酰胺腺嘌呤二核苷酸磷酸氧化酶介导肿瘤坏死因子-α在脑血管内皮细胞中引起的氧化应激和细胞凋亡。
Am J Physiol Cell Physiol. 2009 Mar;296(3):C422-32. doi: 10.1152/ajpcell.00381.2008. Epub 2008 Dec 31.
8
Distinct roles of Nox1 and Nox4 in basal and angiotensin II-stimulated superoxide and hydrogen peroxide production.Nox1和Nox4在基础状态及血管紧张素II刺激下超氧化物和过氧化氢生成中的不同作用。
Free Radic Biol Med. 2008 Nov 1;45(9):1340-51. doi: 10.1016/j.freeradbiomed.2008.08.013. Epub 2008 Aug 16.
9
EGFR targeting of solid tumors.实体瘤的表皮生长因子受体靶向治疗
Cancer Control. 2007 Jul;14(3):295-304. doi: 10.1177/107327480701400313.
10
NOX4 activity is determined by mRNA levels and reveals a unique pattern of ROS generation.NOX4活性由mRNA水平决定,并揭示了一种独特的活性氧生成模式。
Biochem J. 2007 Aug 15;406(1):105-14. doi: 10.1042/BJ20061903.